Clinical Trial Update: A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

This document summarizes the completion of a long-term Phase 3 study evaluating aripiprazole for major depressive disorder. The trial is sponsored by Otsuka Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED